Open AccessAscites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging
Author(s) -
Asmaa Gomaa,
Alzhraa Alkhatib,
Wael AbdelRazek,
Mohamed Hashim,
Imam Waked
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i18.5654
Subject(s) - ascites , medicine , hepatocellular carcinoma , gastroenterology , cirrhosis , liver cancer , liver disease , alpha fetoprotein , hepatic encephalopathy , stage (stratigraphy) , biology , paleontology
To assess how ascites and alpha-fetoprotein (AFP) added to the Barcelona Clinic Liver Cancer (BCLC) staging predict hepatocellular carcinoma survival.